| 1 | Energy | XLE | +42.7% |
| 2 | Technology | XLK | +30.1% |
| 3 | Materials | XLB | +10.5% |
| 4 | Industrials | XLI | +9.1% |
| 5 | Real Estate | XLRE | +7.5% |
| 6 | Consumer Staples | XLP | +7.3% |
| 7 | Healthcare | XLV | +6.3% |
| 8 | Financials | XLF | +4.2% |
| 9 | Utilities | XLU | -1.8% |
| 10 | Communication | XLC | -3.7% |
| 11 | Consumer Disc. | XLY | -4.6% |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q2 '26 | 8/5/26 | $0.84 | $0.91 | +8.3% | +21% | $0.6B | $0.6B | -0.8% | +11% |
| Q1 '26 | 5/5/26 | $0.74 | $0.87 | +17.6% | +40% | $0.6B | $0.6B | +0.7% | +10% |
| Q4 '25 | 2/10/26 | $0.76 | $0.94 | +23.7% | +71% | $0.6B | $0.6B | +0.7% | +6% |
| Q3 '25 | 11/4/25 | $0.63 | $0.78 | +23.8% | +66% | $0.6B | $0.6B | +1.4% | +11% |
| Q2 '25 | 7/28/25 | $0.61 | $0.75 | +22.9% | -11% | $0.6B | $0.6B | -1.6% | -11% |
| Q1 '25 | 5/13/25 | $0.44 | $0.62 | +40.9% | +265% | $0.5B | $0.6B | +10.9% | +31% |